BioClinica
Global clinical trial solutions. Real-world results.
- Solutions
- Science Library
- Support
- Partners
- About Us
*NEWTOWN, PA, March 4, 2010* – BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced it has created strategic partnerships with two clinical research organizations (CROs), Health Sciences International, Inc., and PRL Central Laboratory Services. Both alliances strengthen the BioClinica Certified Partner Program, a group of VIP CRO partners chosen based on therapeutic expertise and customer satisfaction.
*NEWTOWN, PA, February 25, 2010* – BioClinica™, Inc., (NASDAQ: BIOC), a global provider of clinical trial management services, today announced the launch of BioClinica Optimizer, a breakthrough for clinical supply planning and management that it believes has the potential to transform clinical trial supply forecasting and management. BioClinica Optimizer is a new product that combines and enhances the features of tcVisualize and tcOptimizer developed by Tourtellotte Solutions, which was acquired by BioClinica in September 2009. Allowing a customer to move beyond the current environment of spreadsheets and manual tools to plan and analyze clinical supply chains programmatically, BioClinica Optimizer integrates planning and feedback loops with other eClinical technologies.
*NEWTOWN, PA, February 23, 2010* – BioClinica, Inc. (NASDAQ: BIOC), a global provider of clinical trial management services will participate in, and present at, key industry conferences during February and March. Key members of the BioClinica team will participate as expert panelists as well as demonstrate the value of the Company’s expanded suite of services at these conferences.
*NEWTOWN, PA, February 10, 2010* – BioClinica™, Inc. (NASDAQ: BIOC), a global provider of clinical trial services, today announced its financial results for the quarter and year ended December 31, 2009. The operating results of Phoenix Data Systems (“PDS”) are included in the financial results following the acquisition of PDS that was completed March 24, 2008. The CapMed division, which was sold on January 6, 2009, was reclassified as a discontinued operation for all periods presented.
*NEWTOWN, PA, February 4, 2010* – BioClinica, Inc., (NASDAQ: BIOC) a leading global provider of clinical trial services, has signed a three-year, multi-million dollar deal with Cephalon, Inc. for clinical trial technology and support services. As part of the Service Agreement, US-based data management staff at Cephalon will be hired by BioClinica to support clinical efforts of Cephalon.
As posted on eCliniqua's website:
As posted in The Wall Street Transcript: